Qwoted is a free expert network: we help reporters connect with experts & we help those same experts build relationships with top reporters.
Event Date |
Mon Feb 10 PST - Wed Feb 12 PST (almost 5 years ago)
In your timezone (EST): Mon Feb 10 9:00pm - Wed Feb 12 8:00pm |
Location |
The London West Hollywood
1020 N San Vicente Blvd, West Hollywood, CA 90069, USA |
Region | Americas |
Autism affects about 1 in 59 children, an increase from 1 in 68 two years ago, according to the latest data recently released by the Centers for Disease Control, meaning that 2.5% of the U.S. population has autism. These numbers will likely increase as individuals in underserved markets are better identified and receive an accurate diagnosis.
Because of these growth rates, access to funding and demand for services is increasing exponentially resulting in intense investor interest in this sector. Autism services cost U.S. citizens approximately $250 billion annually, with the individual lifetime cost per person ranging from $1.4 million to $3.2 million depending on the intellectual capacity of each individual.
Currently, the autism services / therapeutic market in the U.S. is conservatively estimated to be valued at $5-7 billion dollars and growing. This includes programs that serve individuals with autism as well as drugs targeting behavioral issues in autism. The supply constraint and the growing demand for services has created a very attractive market that is growing rapidly. Revenues of ABA programs are estimated to generate $2B- 7B annually. These estimates are considered conservative and we believe the market is substantially larger, with a TAM (total addressable market) of up to $70 billion.
The market is highly fragmented with fewer than 10% of the industry owned by consolidators. Demand continues to outweigh supply. In the past two years, five large consolidators have emerged and with significant investment dollars driving the market, the industry is becoming more competitive. Despite this growth, many states and many families remain without adequate services to address the needs of thier children and their communities.
Reasons to Attend:
• Meet one-on-one with industry investors, service providers, investment bankers and professionals
• Learn the latest information on funding, legislation and current deals
• Enhance your personal database with valuable new connections- share both ideas and business cards
• Meet fellow service providers with the opportunity to have new and different conversations regarding the market and future of the industry
• Understand which service models have the most robust outlook and how outcomes will impact the future of autism services
• Hear from investors what they look for when exploring acquisitions
• The right questions to ask when conducting due diligence on companies in the industry.
• Learn about the current critical factors impacting autism service delivery models today
• What to look for in an investor and how to know when investment is right for you
• The keys to differentiation in the market place
2020 Speakers
Adam Abramowitz
Managing Director and Co-Head of Healthcare, Founding Partner, Intrepid Investment Bankers
Bryce Miler
Contracts Director, The Center for Autism and Related Disorders, LLC. (CARD)
Chris McGoff
Founder , The Clearing, Inc.
Chris Sullens
Chief Executive Officer, CentralReach
David Alben
Senior Vice President, Advisory Group
David Long
Managing Partner/Founder, Tuscany Strategy Consulting
Dennis May
Chief Executive Officer and Board Member, Hopebridge
Dexter W. Braff
President, The Braff Group
Eric Scharber
Principal, Simione Healthcare Consultants
Hanna Rue
Head of Clinical Development, LEARN’s
Harry Nelson
Founding Partner, Nelson Hardiman
James Clark
Managing Director, Harris Williams' Healthcare & Life Sciences Group
James Craig
Corporate Vice President for Autism Solutions, Beacon Health Options
Jamie Glazer
Vice President Acute and Post-Acute Revenue Cycle, TeamHealth
Jamie Pagliaro
Chief Learning Officer, Rethink (Autism)
Jonathan Bluth
Director, Co-Head, Healthcare
Jon Krieger
Managing Director, Berkery Noyes
Julie Kornack
Director of Public Policy, Center for Autism and Related Disorders
Matt Serel
Founder, AccuPoint
Michael Cameron
CEO, The Cedar Group
Nick Merkin
Chief Executive Officer, Compliagent
Peter Erickson
Managing Director, TripleTree
Ronit Molko
CEO and Principal, Empowering Synergy
Russell Lehmann
Speaker, Author, Poet, Advocate
Sara Gershfeld Litvak
Chief Executive Officer, Behavioral Health Center of Excellence
Scott Klososky
Author
Thomas Reilly
Consultant
Whit Knier
Director, Harris Williams' Healthcare & Life Sciences Group
Yagnesh Vadgama BCBA
Vice President, Clinical Care Services Autism
2020 Sponsors
HEADLINE SPONSOR:
• Braff
LEADERSHIP SPONSOR:
• BRG Berkeley Research Group
• Berkerey Noyes
• Data Finch Technologies
WELCOME RECEPTION SPONSOR:
• CentralReach
ROOFTOP & VIP NETWORKING RECEPTION SPONSOR:
• CodeMetro
ABA/PE SPEED-DATING SPONSOR:
• Intrepid
GOLD LEVEL SPONSORS:
• Chorus
• HW Harris Williams
• TuscanyStrategy Consulting
• Simione
• TripleTree
• TTCP
SILVER LEVEL SPONSORS:
• Marwood Group
• Polsinelli
• rethink